指南与共识术前评估与围术期医学心胸血管麻醉

ESAIC非心脏手术成人术中血流动力学监测与管理声明

Intra-operative haemodynamic monitoring and management of adults having noncardiac surgery: A statement from the European Society of Anaesthesiology and Intensive Care.
指南 / 共识 · Eur J Anaesthesiol · 2025-05-07

欧洲麻醉与重症学会组织25名国际专家,基于现有证据综述制定成人非心脏手术术中血流动力学监测与管理推荐,建议以平均动脉压为目标并保持术中平均动脉压高于60 mmHg,同时识别并处理低血压病因,不建议仅因液体反应性而补液。

要点

  • 术中平均动脉压应维持在60 mmHg以上。
  • 应识别术中低血压的潜在病因并予以适当处理。
  • 不建议仅因液体反应性而补液,仅在低血容量或组织低灌注征象时补液。

核心结论

  • 推荐基于平均动脉压进行术中动脉压管理,并保持术中平均动脉压高于60 mmHg。

研究设计与样本

  • 由欧洲麻醉与重症学会(ESAIC)25名国际专家基于现有证据综述制定推荐。

主要发现

  • 推荐识别术中低血压的潜在病因并适当处理。
  • 建议在基线并发症高风险或高危手术患者中监测每搏量或心输出量以评估血流动力学状态及治疗反应。
  • 推荐不应常规最大化每搏量或心输出量,而应结合临床情况与组织灌注和氧合的临床及代谢征象为每位患者个体化设定目标。
  • 推荐不应仅因患者液体反应性而补液,仅在存在低血容量或组织低灌注的临床或代谢征象时补液。
  • 建议监测并优化麻醉深度以滴定麻醉药物剂量并减少其副作用。

关键数值与推荐

  • 推荐术中平均动脉压保持在60 mmHg以上。
  • 建议对高风险患者或高危手术监测每搏量或心输出量。
  • 推荐不常规最大化每搏量或心输出量。
  • 推荐不单纯依据液体反应性补液。

临床怎么用

  • 术中动脉压管理以平均动脉压为目标,维持平均动脉压高于60 mmHg。
  • 出现低血压时应查找并处理潜在病因。
  • 对高风险患者或高危手术可监测每搏量或心输出量评估血流动力学状态及治疗反应。
  • 仅在存在低血容量或组织低灌注临床或代谢征象时补液,不因液体反应性常规补液。
  • 监测并优化麻醉深度以滴定麻醉药物剂量并减少副作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article was developed by a diverse group of 25 international experts from the European Society of Anaesthesiology and Intensive Care (ESAIC), who formulated recommendations on intra-operative haemodynamic monitoring and management of adults having noncardiac surgery based on a review of the current evidence. We recommend basing intra-operative arterial pressure management on mean arterial pressure and keeping intra-operative mean arterial pressure above 60 mmHg. We further recommend identifying the underlying causes of intra-operative hypotension and addressing them appropriately. We suggest pragmatically treating bradycardia or tachycardia when it leads to profound hypotension or likely results in reduced cardiac output, oxygen delivery or organ perfusion. We suggest monitoring stroke volume or cardiac output in patients with high baseline risk for complications or in patients having high-risk surgery to assess the haemodynamic status and the haemodynamic response to therapeutic interventions. However, we recommend not routinely maximising stroke volume or cardiac output in patients having noncardiac surgery. Instead, we suggest defining stroke volume and cardiac output targets individually for each patient considering the clinical situation and clinical and metabolic signs of tissue perfusion and oxygenation. We recommend not giving fluids simply because a patient is fluid responsive but only if there are clinical or metabolic signs of hypovolaemia or tissue hypoperfusion. We suggest monitoring and optimising the depth of anaesthesia to titrate doses of anaesthetic drugs and reduce their side effects.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Saugel B, Buhre W, Chew MS, et al. Intra-operative haemodynamic monitoring and management of adults having noncardiac surgery: A statement from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol. 2025. PMID: 40308048. doi:10.1097/EJA.0000000000002174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。